Clinical Trials Browser

Phase 2 × Mycoses × Antilymphocyte Serum × Clear all

NCT00896493 2023-05-11

Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma

Phase 2 Completed

38 enrolled 21 charts

DermatologicLymphoid

Lymphoma, Non-Hodgkin, Mycoses, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous